Directors Byron PickardTrey PowersChandrika ViraWilliam MillikenAnna Phillips, and Tyler Dutton were mentioned as representing TwinStrand Biosciences in the Mealey’s article “Delaware Jury: Guardant Willfully Infringed Patents With DNA Sequencing Kits.” The following is an excerpt from the article:

“Jurors empaneled in Delaware federal court delivered a win to the owner and exclusive licensee of two cancer-detection patents, deeming the technology willfully infringed by Guardant Health Inc.

The University of Washington and TwinStrand Biosciences Inc. (TwinStrand, collectively) on Nov. 14 were awarded $83.4 million by the jury, representing a 6% royalty on Guardant’s $1.39 billion royalty base.”

To read the full article, please click the “Download PDF” button.

Reprinted from Mealey's Litigation Report: Intellectual Property, November 20, 2023, Volume 32, Issue 4 with permission. Copyright 2023 LexisNexis, a division of Reed Elsevier Inc. All rights reserved